Psychotropics and weight gain;Les psychotropes et la prise pondérale

Praxis

Volumn 93, Issue 35, 2004, Pages 1393-1401

  Sahli, Ch ^a   Bryois, Ch ^a  

^a Hôpital Psychiatrique de Prangins   (Switzerland)

Author keywords

Psychotropics; Weight gain

Indexed keywords

EID: 80051665423     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.93.35.1393     Document Type: Review

References (52)

1. James Philip T, Rachel Leach, Eleni Kalamara, Maryam Shayeghi. The Worldwide Obesity Epidemic. Obesity research. 2001; 9 (suppl 4): 228S-233S.
2. Ilsemarie Kurzthaler and W Wolfgang Fleischhacker. The clinical Implications of Weight Gain in Schizophrenia. J Clin Psychiatry.2001; 62 (suppl 7): 32-37.
3. Ulrich Zimmermann, Thomas Kraus, Hubertus Himmerich, Andreas Schuld and Thomas Pollmächer. Epidemiology, Implications and Mechanims Underlying Drug-Induced Weight Gain in Psychiatric Patients. Journal of Psychiatric Research. 2003; 37, issue 3: 193-220.
4. Christian Bryois. La psychopharmacothérapie dans le domaine de la psychiatrie adulte. Revue Médicale de la Suisse Romande. 2000; 120: 123-129.
5. David B Allison and Daniel E. Casey. Antipsychotic-Induced Weight Gain: A review of the Literature. J Clin Psychiatry. 2001; 62 (suppl 7): 22-31.
6. David B Allison, Janet L Mentore, Moonseong Heo, Linda P Chandler, Joseph C Cappelleri, Ming C Infante, and Peter J Weiden. Antipsychotic-induced Weight Gain: A Comprehensive Research Synthesis. Am. J. Psychiatry. 1999; 156 (11): 1686-1696.
7. Timan Wetterling, Heidi E MuBigbrodt. Weight Gain: Side Effect of Atypical Neuroleptics. Journal of Psychopharmacology. 1999; 19 (4): 316-321.
8. Barry Jones, Bruce R Basson, Daniel J Walker, Ann Marie K Crawford, Bruce J Kinon. Weight Change and Atypical Antipsychotic Treatment in Patients With Schizophrenia. J Clin Psychiatry. 2001; 62 (suppl 2): 41-44.
9. Taylor DM, McAskill R. Atypical Antipsychotics and Weight Gain: A Systematic Review. Acta Psychiatr Scand. 2000; 101: 416-432. (Pubitemid 30365564)
10. Donna A Wirshing, William C Wirshing, Lisa Kysar, M Andrew Derisford, Danielle Goldstein, Stephen Marder. Novel Antipsychotics: Comparison of Weight Gain Liabilities. J Clin Psychiatry. 1999; 60 (6): 358-363.
11. N. Nasrallah. A Review of the effect of Atypical Antipsychotics on Weight. Psychoneuroendocrynology. 2003; 28: 83-96.
12. Martina Hummer, Georg Kemmler, Martin Kurz, Ilse Kurzthaler, Harald Oberbauer, W Wolfgang Fleischhacker. Weight Gain Induced by Clozapine. European Neuropsychopharmacology. 1995; 5: 437-440.
13. David C Henderson. Clozapine: Diabetes Mellitus, Weight Gain and Lipid Abnormalities. J Clin Psychiatry. 2001; 62 (suppl 23): 39-44.
14. Martin Brecher, Wayne Geller. Weight Gain With Risperidone. Journal of Clinical Psychopharmacology. 1997; 17(5): 435-436.
15. Rohan Ganguli, Jaspreet S Brar, Zenia Ayrton. Weight Gain Over 4 Months in Schizophrenia Patients: A Comparison of Olanzapine and Risperidone. Schizophrenia research. 2001; 49: 261-267.
16. Kathleen E Bryden, and Lili C Kopala. Body Mass Index Increase of 58% Associated With Olanzapine. Am J Psychiatry. 1999; 156: 1835-1836.
17. David N Osser, Dean M Najarian, Robert L Dufresne. Olanzapine Increases Weight and Serum Triglyceride Level. J Clin Psychiatry. 1999; 60 (11): 767-770.
18. Sanjay Gupta, Thomas Droney, Sadiq Al-Samarrai, Peggy Keller, Bradforf Frank. Olazapine:Weight Gain and Therapeutic Efficacy. Journal of Clinical Psychopharmacology. 1999; 19 (3): 273-275.
19. Ursula Eder, Barbara Mangweth, Christoph Ebenbichler, Elisabeth Weiss, Alex Hofer, Martina Hummer, W Wolfgang Fleischhacker. Association of Olanzapine- Induced Weight Gain With an Increase in Body Fat. Am J Psychiatry. 2001; 158: 1719-1722.
20. K-M Haapasalo-Pesu, S Saarijärvi. Olanzapine Induces Remarkable Weight Gain in Adolescent Patients. European Child&Adolescent Psychiatry. 2001; 10: 205-208. (Pubitemid 32904928)
21. Murad Atmaca, Murat Kuloglu, Ertan Tezcan, Omer Gecici. Weight Gain, Serum Leptin and Triglyceride Levels in Patients With Schizophrenia on Antipsychotic Treatment With Quetiapine, Olanzapine and Haloperidol. Schizophenia Research. 2003; 60: 99-100.
22. Charles B Nemeroff. Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain. J Clin Psychiatry. 2003; 64(5):532-539
23. B Mathew, J Murti Rao, U Sundari. Lithium-Induced Changes in the Body Mass Index. Acta Psychiatry Scand. 1989; 80: 538-540. (Pubitemid 20046936)
24. T Baptista, L Teneud, Q Contreras, T Alastre, J L Burguera, S Weiss, L Hernandez. Lithium and Body Weight Gain. Pharmacopsychiatry. 1995; 28: 35-44.
25. Murad Atmaca, Murat Kuloglu, Ertan Tezcan, Bilal Ustundag. Weight Gain and Serum Leptin Levels in Patients on Lithium Treatment. Neuro psychobiology. 2002; 46: 67-69.
26. H N Ranganath. Carbamazepine and Weight Gain: Letter to Editer. Neurology India. 2000; 48: 299.
27. A Verrotti, F Basciani, S Morresi, M de Martino, G Morgese, F Chiarelli. Serum Leptin Changes In Epileptic Patients Who Gain Weight After Therapy With Valproic Acid. Neurology. 1999; 53 (1): 230.
28. Elaine C Wirrell. Valproic Acid-Associated Weight Gain in Older Children and Teens with Epilepsy. Pediatric Neurology. 2003; 28(2): 126-129.
29. Michael van Ameringen, Catherine Mancini, Beth Pipe, Mira Campbell, Jonathan Oakman. Topiramate Treatment for SSRI-Induced Weight Gain in Anxiety Disorders. J Clin Psychiatry. 2002; 63(11): 981-984.
30. Emmanuelle Levy, Howard C Margolese, Guy Chouinard. Topiramate Produced Weight Loss Following Olanzapine-Induced Weight Gain in Schizophrenia. J Clin Psychiatry. 2002; 63 (11): 1045.
31. Alan Gordon, Lawrence H Price. Mood Stabilization and Weight Loss with Topiramate. Am J Psychiatry. 1999; 156 (6): 968-969.
32. Maurizio Fava. Weight Gain and Antidepressants. J Clin Psychiatry. 2000; 61 (suppl 11): 37-41.
33. C Bryois, Ph Delacrausaz, S Didisheim. Antidépresseurs et maladie somatique. Praxis.1999; 88: 1351-1356.
34. Madelyn H Fernsrtom and David J Kupfer. Antidepressant-Induced Weight Gain: A Comparison Study of Four Medications. Psychiatry Research. 1988. 26: 265-271.
35. Ellen Frank, David J Kupfer, Cynthia M Bulik and Janet A Levenson. Imipramine and Weight Gain During the Treatment of Recurrent Depression. Journal of Affective Disorders. 1990; 20: 165-172.
36. Ellen Frank, David J Kupfer, Alhaji Buhari, Ann B McEachran, Victoria J. Grochocinski. Imipramine and Weight Gain During the Long-Term Treatment of Recurrent Depression. Journal of Affective Disorders. 1992; 26: 65-72.
37. Brian H Harvey, Colin D Bouwer. Neuropharmacology of Paradoxic Weight Gain with Selective Serotonin Reuptake Inhibitors. Clinical Neuropharmacology. 2000; 23 (2): 90-97.
38. Maurizio Fava, Rajinder Judge, Sharon L Hoog, Mary E Nilson, Stephanie C Koke. Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder: Change in Weight With Long-term Treatment. J Clin Psychiatry. 2000; 61 (11): 863-867.
39. Christina D Chambers, Philip O Anderson, Ronald G Thomas, Lyn M Dick, Robert J Felix, Kathleen A Johnson, Kenneth Lyons Jones. Weight Gain in Infants Breastfed by Mothers Who Take Fluoxetine. Pediatrics. 1999; 104 (5): 1-5.
40. Harry Croft, Trisha L Houser, Brenda D Jamerson, Robert Leadbetter, Carolyn Bolden-Watson, Rafe Donahue, Alan Metz. Effect on Body Weight of Bupropion Sustained-Release in Patients with Major Depression Treated for 52 Weeks. Clinical Therapeutics. 2002; 24 (4): 662-672.
41. Randy Sansone, Michael W Wiederman, John Shrader. Naturalistic Study of the Weight Effects of Amitriptyline, Fluoxetine and Sertraline in an Outpatient Medical Setting. Journal of Clinical Psychopharmacology. 2000; 20 (2): 272-273.
42. Maria E Fisfalen, Robert C Hsiung. Glucose Dysregulation and Mirtazapine-Induced Weight Gain. Am J Psychiatry. 2003; 160 (4): 797.
43. G Abraham. Massive Weight Gain and Hostility Force Mirtazapine Stop. Canadian Psychiatric Association. 2002.
44. Hiroki Fukui, Toshiya Murai. Severe Weight Gain Induced by Combination Treatment With Risperidone and Paroxetine. Clinical Neuropharmacology. 2002; 25 (5): 269-271.
45. M Kazes, J M Danion, D. Grangé, A Pradignac, Ch Simon, F Burrus-Mehl, L Singer. Eating Behaviour and Depression Before and After Antidepressant Treatment: A Prospective, Naturalistic Study. Journal of Affective Disorders. 1994; 30: 193-207. (Pubitemid 24087684)
46. Gavin P Reynolds, Zhi-Jun Zhang, Xiao-Bin Zhang. Associated of Antipsychotic Drug-Induced Weight Gain with a 5-HT2c receptor Gene Polymorphism. The Lancet. 2002. 359: 2086-2087.
47. Vincenro S Basile, Mario Masellis, Roger S McIntyre, Herbert Y Meltzer, Jeffrey A Lieberman, James L. Kennedy. Genetic Dissection of Atypical Antipsychotic-Induced Weight Gain: Novel Preliminary Data on the Pharmacogenetic Puzzle. J Clin Psychiatry. 2001; 62 (suppl 23) : 45-66.
48. Christopher D O'Keefe, Douglas L Noordsy, Thomas B Liss, Honey Weiss. Reversal of Antipsychotic-Associated Weight Gain. J Clin Psychiatry. 2003; 64 (8): 907-912.
49. Daniel Umbricht, Heidi Flury, René Bridler. Cognitive Behavior Therapy for Weight Gain. Am J Psychiatry. 2001; 158 (6): 971.
50. Documed SA, Compendium suisse des médicaments 2003, Bâle, 2002.
51. Paul E Kerk Jr, Susan L McElroy. Aripiprazole: A Partial Dopamine D2 Receptor Agonist Antipsychotic. Expert Opin Investig Drugs. 2003; 12(4): 655-662.
52. Paul J Goodnick, Jason M Jerry. Aripiprazole: Profile on Efficacy and Safety. Expert Opin Pharmacother. 2002; 3 (12): 1773-1781.